Question 1

What is the catalog number for ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued?

Accepted Answer

The catalog number for ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued is 031581-APC.

Question 2

What sizes are available for ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued?

Accepted Answer

ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued is available in the following size(s): 200 µL.

Question 3

Is ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued in stock?

Accepted Answer

ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 5

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Question 6

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

ACTL8, ID (ACTL8, Actin-like protein 8, Cancer/testis antigen 57) (APC) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/3772R), CF568 conjugate, 0.1mg/mL

CD44v6 (Marker of Tumor Metastasis) (CD44V6/2496), CF405S conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL

Insulin-like Growth Factor-1 (IGF-1) (IGF1/2872R), CF594 conjugate, 0.1mg/mL

CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/3126R), CF740 conjugate, 0.1mg/mL

Bcl-6 (Follicular Lymphoma Marker) (rBCL6/1718), Biotin conjugate, 0.1mg/mL